
Researchers investigated the relationship between visual functioning measured using the National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25) and mortality in patients with various stages of AMD.

Researchers investigated the relationship between visual functioning measured using the National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25) and mortality in patients with various stages of AMD.

The financing will help advance the company’s novel treatment system for glaucoma and other chronic ophthalmic diseases.

Procedures in the pipeline hold greater appeal for cataract and refractive surgeons, patients.

Immediate past president of AOSA Easy Anyama speaks on the latest initiatives of the student organization at NOA 2023 in Fort Lauderdale, Florida.

Isa Prude, president of NOSA, speaks on the Diversifying Optometry Initiative at NOA 2023.

Jacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on squamous cell carcinoma of the conjunctiva, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.

Brianna Rhue, OD, FAAO, FSLS, met with Optometry Times to talk about her presentation titled, "Myopia- How and Now," which she will be sharing at the National Optometric Association in Fort Lauderdale, Florida.

Jacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on neurotrophic keratits, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.

Catch up on what happened in optometry during the week of July 3-July 7.

Nwamaka Ngoddy, OD, founder of Anwuli Eye Wear, gives us a brief look into her inclusive line of frames during NOA 2023.

Pierce Kenworthy, OD, met with Optometry Times to talk about his course titled, "Eyelid Conjunctive Growths & Degenerations: From Benign to Terrifying," which he will be presenting at the National Optometric Association 2023 annual convention in Fort Lauderdale, Florida.

These 3 types of fixational eye movements play a vital role in our visual perception, cognitive function, and are instrumental for our ability to see the world around us.

The product line will be acquired for $106.5 million, and will add another half dozen products to the company’s over-the-counter eye care product portfolio.

These findings demonstrate the exact association between high myopia and changes in the ocular blood flow, which heretofore had not been established.

The meeting took place on Capitol Hill in Washington, DC, from June 21-24, and hosted the AOA+ experiences for students, faculty, and new doctors in the field; as well as the AOA’s single-largest annual advocacy event, AOA on Capitol Hill.

Prevent Blindness aims to educate the public on dry eye through free resources including fact sheets and social media graphics for Dry Eye Awareness Month.

A new study titled, “Prevalence of Diabetic Retinopathy in the US in 2021,” finds that almost 10 million people in the United States with diabetes have diabetic retinopathy.

Take a look back at the first half of 2023 as we explore the role of AI in the eye care field in anticipation of the changes to come.

Catch up on what happened in optometry during the week of June 26-June 30.

The company has entered a definitive agreement with Novartis to acquire Xiidra (liftegrast ophthalmic solution 5%), representing a significant opportunity for growth in prescription dry eye.

A recently completed non-human primate study of VGX-0111 demonstrated good tolerability, provided strong transgene expression in the targeted region of the retina, and increased production of the lipids whose decline is associated with macular degeneration.

Keratopigmentation technique offers therapeutic and cosmetic applications.

Horizon Therapeutics announced the Brazilian Health Regulatory Agency (ANVISA) has approved TEPEZZA as the first and only medicine approved in Brazil for treatment of thyroid eye disease.

Sparklers and firecrackers are at the top of the list for fireworks-related injuries. The organization is advising the public to leave fireworks to licensed operators.

The company announced the Complete Letter Response from the FDA for the Biologics License Application for aflibercept 8 mg is “solely due to an ongoing review of inspection findings at a third-party filler."

Erich A. Hinel, OD, MS, FAAO, Dipl ABO, discusses the use of 3-layer amniotic membrames to treat severe keratoconjunctivitis sicca, severe dry eye, and ocular surface disease.

Jacqueline Theis, OD, FAAO, discusses photophobia and how to most effectively treat this patient population, including when and how to utilizing blue light blockers.

Maria Richman, OD, FAAO, and Harvey Richman, OD, FAAO, FCOVD, met with Optometry Times to discuss their presentations on rehabilitation of a patient who suffered from issues of vertical vision after a stroke, as well as integrating patient care with the business model.

At the AOA Optometry's Meeting 2023, Jonathan Etter, MD, FAAO, presented with Susan Gromacki, OD, MS, FAAO, FSLS, on the OD and MD perspectives on keratoconus and collagen crosslinking.

Clark Chang, OD, MSA, MSc, FAAO, meets with Optometry Times to discuss HOA-correcting scleral lens at AOA in Washingtion, DC.